Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00931372
What this trial is testing

Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 22
Early research (Phase 1)Study completedNCT01044537
What this trial is testing

A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 50
Large-scale testing (Phase 3)Study completedNCT02100475
What this trial is testing

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 31
Large-scale testing (Phase 3)Study completedNCT00251680
What this trial is testing

Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.

Who this might be right for
Type 2 Diabetes
Takeda 400
Large-scale testing (Phase 3)Study completedNCT05702073
What this trial is testing

To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin.

Who this might be right for
Type 2 Diabetes Mellitus
Jiangsu HengRui Medicine Co., Ltd. 423
Early research (Phase 1)Study completedNCT01535677
What this trial is testing

To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 71
Large-scale testing (Phase 3)Study completedNCT00643851
What this trial is testing

An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets

Who this might be right for
Type 2 Diabetes
AstraZeneca 994
Early research (Phase 1)Study completedNCT01956305
What this trial is testing

Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study

Who this might be right for
Type 2 Diabetes Mellitus
Daiichi Sankyo 48
Not applicableEnded earlyNCT02443753
What this trial is testing

EndoBarrier® SANS™ in Over-weight or Obese Type 2 Diabetic Subjects

Who this might be right for
ObesityType 2 Diabetes
Morphic Medical Inc. 7
Post-approval studies (Phase 4)Study completedNCT04153981
What this trial is testing

Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 304
Early research (Phase 1)Ended earlyNCT00943371
What this trial is testing

A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 28
Early research (Phase 1)Study completedNCT01757756
What this trial is testing

Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders
Pfizer 12
Early research (Phase 1)Study completedNCT01290575
What this trial is testing

Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Bristol-Myers Squibb 67
Testing effectiveness (Phase 2)Study completedNCT05762471
What this trial is testing

Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Overweight or ObesityType2 Diabetes Mellitus
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 142
Early research (Phase 1)Study completedNCT01473953
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 31
Testing effectiveness (Phase 2)Study completedNCT01845064
What this trial is testing

Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients

Who this might be right for
Diabetes Type 2
DiaMedica Therapeutics Inc 98
Early research (Phase 1)Ended earlyNCT02686281
What this trial is testing

Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes

Who this might be right for
Healthy
Genmedica Therapeutics S.L. 19
Testing effectiveness (Phase 2)Ended earlyNCT02053116
What this trial is testing

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 8
Large-scale testing (Phase 3)Study completedNCT04504370
What this trial is testing

Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
PegBio Co., Ltd. 273
Testing effectiveness (Phase 2)Study completedNCT02713841
What this trial is testing

Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Dance Biopharm Inc. 12
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation